Categories Investing
Categories Investing
Breaking the NIMBY Feedback Loop in Vermont
March 7, 2025
Stephen Slivinski and Yasmeen Kallash-Kyler
Categories Investing
Trump’s Tariff Walkback Bows to Economic Reality but Leaves Plenty of Problems
March 7, 2025
Alfredo Carrillo Obregon and Scott Lincicome
Categories Investing
The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine
March 7, 2025
Jeffrey A. Singer
Categories Investing
Friday Feature: Education Collaboration Network
March 7, 2025
Colleen Hroncich Remote pandemic schooling wasn’t working for her second-grade daughter, so Rebecca Simmons decided it was a good time to start homeschooling.
Categories Investing
The US Tax and Transfer System Has Become More Progressive
March 7, 2025
Jeffrey Miron and Jacob Winter
Categories Investing
Evaluating PDUFA: Paying for FDA Drug-Application Reviewers by Charging User Fees
March 7, 2025
Michael F. Cannon A congressional staffer recently asked about the performance of the Food and Drug Administration (FDA), including the Prescription Drug User
Categories Investing
10 Reasons to Cut Corporate Welfare
March 6, 2025
Chris Edwards Congress should cut federal spending to reduce massive budget deficits. One target for reform should be business subsidies—often called corporate welfare—which
Categories Investing
As the United States Cracks Down on Fentanyl Smuggling, New Drugs and Suppliers Emerge
March 6, 2025
Jeffrey A. Singer The Drug Enforcement Administration reported last year that its heroin seizures decreased by almost 70 percent, while its fentanyl seizures
Categories Investing